- Home
- TMDX vs SGRY Comparison
TMDX vs SGRY Comparison
Compare TMDX & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- SGRY
- Stock Information
- Founded
- TMDX 1998
- SGRY 2004
- Country
- TMDX United States
- SGRY United States
- Employees
- TMDX N/A
- SGRY N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SGRY Hospital/Nursing Management
- Sector
- TMDX Health Care
- SGRY Health Care
- Exchange
- TMDX Nasdaq
- SGRY Nasdaq
- Market Cap
- TMDX 4.7B
- SGRY 3.9B
- IPO Year
- TMDX 2019
- SGRY 2015
- Fundamental
- Price
- TMDX $86.26
- SGRY $24.65
- Analyst Decision
- TMDX Buy
- SGRY Buy
- Analyst Count
- TMDX 10
- SGRY 8
- Target Price
- TMDX $138.20
- SGRY $40.71
- AVG Volume (30 Days)
- TMDX 2.2M
- SGRY 911.6K
- Earning Date
- TMDX 10-28-2024
- SGRY 11-12-2024
- Dividend Yield
- TMDX N/A
- SGRY N/A
- EPS Growth
- TMDX N/A
- SGRY N/A
- EPS
- TMDX 0.94
- SGRY N/A
- Revenue
- TMDX $401,090,000.00
- SGRY $2,985,300,000.00
- Revenue This Year
- TMDX $83.25
- SGRY $14.72
- Revenue Next Year
- TMDX $26.27
- SGRY $9.56
- P/E Ratio
- TMDX $94.29
- SGRY N/A
- Revenue Growth
- TMDX 109.09
- SGRY 9.96
- 52 Week Low
- TMDX $63.86
- SGRY $22.25
- 52 Week High
- TMDX $177.37
- SGRY $36.92
- Technical
- Relative Strength Index (RSI)
- TMDX 31.88
- SGRY 30.03
- Support Level
- TMDX $82.70
- SGRY $28.62
- Resistance Level
- TMDX $98.88
- SGRY $31.89
- Average True Range (ATR)
- TMDX 5.52
- SGRY 1.50
- MACD
- TMDX 1.30
- SGRY -0.23
- Stochastic Oscillator
- TMDX 15.58
- SGRY 1.91
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.